On this page
Actimmune
interferon gamma-1b
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Actimmune
Proper name
interferon gamma-1b
Licence type
351(a)
BLA number
103836
Applicant
Horizon Therapeutics Ireland DAC
Center
CDER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 100MCG(2MILLION INTERNATIONAL UNITS)/0.5ML | Injection | Subcutaneous | Single-Dose Vial | Rx | February 25, 1999 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | February 10, 2007 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |